News

MedPage Today on MSN2d
CVS Drops Obesity Drug; Once-Weekly Growth Hormone; WeightWatchers' Bankruptcy
People prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...
WGRZ3d
CVS opts for Wegovy over Zepbound, affecting drug access for some
NEW YORK — CVS ... obesity medications known as GLP-1 receptor agonists that have soared in popularity due to the amount of weight people lose while taking the injections. Coverage of these ...
WHAS11 News13d
Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health
INDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health ... part of a wave of obesity medications ...
Managed Healthcare Executive13d
FDA Sets Action Date for Oral Wegovy for Weight Loss
A decision is expected in the fourth quarter of 2025.
Seattle Times3d
Why patients are being forced to switch to a 2nd-choice obesity drug
He said the deal would reduce the price that Caremark’s employer clients paid for obesity drugs by 10% to 15% compared with the previous year. Advertising “CVS Caremark was able to do what ...
WTHR13d
Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health
INDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs ... Wegovy and Zepbound are part of ...